Mondelez Q2 Earnings Beat, Raises 2026 Organic Growth Guidance to At Least 2%
MDLZ sits 24% above its 52-week low of $51.201.
Summary
Mondelez beat Q2 estimates and issued 2026 organic growth guidance of at least 2%, while disclosing CEO Van de Put's 10b5-1 plan to sell up to 577,767 shares.
Key Events · Earnings and Guidance · MDLZ
-
Q2 Earnings Beat
Revenue of $9.36B topped the $9.20B consensus; adjusted EPS of $0.73 beat the $0.71 estimate. GAAP diluted EPS was $1.20, up 145% YoY, driven by favorable mark-to-market derivative gains.
-
2026 Guidance Initiated
Management guided to at least 2% organic net revenue growth for 2026, providing a concrete floor after previously only offering qualitative commentary.
-
CEO Adopts 10b5-1 Trading Plan
CEO Dirk Van de Put adopted a Rule 10b5-1 plan on May 15, 2026 to sell up to 577,767 shares over the next year, plus additional shares from PSU vesting.
-
New CFO Compensation Disclosed
Exhibit 10.1 reveals new CFO Amit Banati's offer letter: $1.05M base salary, $5M equity grant, and a $7M make-whole cash award, with clawback provisions.
Analysis · MDLZ · Manufacturing
Mondelez delivered a clean Q2 beat with revenue of $9.36B topping the $9.20B consensus and adjusted EPS of $0.73 beating the $0.71 estimate. More importantly, management provided concrete 2026 guidance for the first time, calling for at least 2% organic net revenue growth — a floor that removes uncertainty after a volatile cocoa cost environment. The quarter also revealed CEO Dirk Van de Put adopted a 10b5-1 trading plan in May to sell up to 577,767 shares, a notable insider disposition signal. New CFO Amit Banati's employment terms were disclosed, showing a $7M make-whole cash award and $5M equity grant.
At the time of this filing, MDLZ was trading at $63.68 on NASDAQ in the Manufacturing sector, with a market capitalization of approximately $80.2B. The 52-week trading range was $51.20 to $70.33. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.